---
title: "Curatis and Neupharma sign development agreement for corticorelin in Japan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278862080.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-03-12T10:13:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278862080.md)
  - [en](https://longbridge.com/en/news/278862080.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278862080.md)
generator: "portal-rs"
---

# Curatis and Neupharma sign development agreement for corticorelin in Japan

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [3671.JP](https://longbridge.com/en/quote/3671.JP.md)
- [4528.JP](https://longbridge.com/en/quote/4528.JP.md)

## Related News & Research

- [Mediar and Ono Pharmaceutical to develop fibro-inflammatory treatments](https://longbridge.com/en/news/295211168.md)
- [ONO Pharma says Taiwan approves Opdivo perioperative regimen for resectable NSCLC](https://longbridge.com/en/news/296309213.md)
- [Kynexis pockets €97m to advance cognition-focused schizophrenia drug](https://longbridge.com/en/news/296501085.md)
- [Reformed pharmaceutical regulation across India’s drug landscape](https://longbridge.com/en/news/296321423.md)
- [Enrolment concludes in Lynch’s Phase II rhPDGF-BB study](https://longbridge.com/en/news/296343171.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**